Chemed (CHE)
(Delayed Data from NYSE)
$417.85 USD
+5.55 (1.35%)
Updated Aug 1, 2025 03:58 PM ET
After-Market: $417.79 -0.06 (-0.01%) 7:58 PM ET
5-Strong Sell of 5 5
C Value A Growth F Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2025
Time: -- |
9/2025 | $5.41 | 0.00% |
Earnings Summary
For their last quarter, Chemed (CHE) reported earnings of $4.27 per share, missing the Zacks Consensus Estimate of $4.78 per share. This reflects a negative earnings surprise of 10.67%. Look out for CHE's next earnings release expected on November 04, 2025. For the next earning release, we expect the company to report earnings of $5.41 per share, reflecting a year-over-year decrease of 4.08%.
Earnings History
Price & Consensus
Zacks News for CHE
ASTH vs. CHE: Which Stock Is the Better Value Option?
CHE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Analysts Estimate Chemed (CHE) to Report a Decline in Earnings: What to Look Out for
ASTH or CHE: Which Is the Better Value Stock Right Now?
Reasons to Add Align Technology Stock to Your Portfolio Now
CHE FAQs
Chemed Corporation (CHE) has announced they will report their next quarter earnings on November 04, 2025. For the next earning release, we expect the company to report earnings of $5.41 per share, reflecting a year-over-year decrease of -4.08%.
Chemed Corporation has announced they will report their previous quarter earnings after the close of the market on November 04, 2025.
The Zacks Consensus Estimate for Chemed Corporation (CHE) for the quarter ending September 2025 is $5.41 a share. We expect Chemed Corporation (CHE) to report earnings in line with the consensus estimate of $5.41 per share
In the earnings report for the quarter ending in September 2024, Chemed Corporation (CHE) announced earnings of $5.64 per share versus the Zacks Consensus Estimate of $5.76 per share, representing a surprise of -2.08%.